Home › Type 2 Diabetes › Alabama › Birmingham
Pag-aaral pangklinika para sa Type 2 Diabetes sa Birmingham, AL
16 pag-aaral para sa Type 2 Diabetes ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Birmingham (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
Nagre-recruit
- University of Alabama, Birmingham
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Nagre-recruit
- University of Alabama, Birmingham
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Nagre-recruitPhase 3
- Cahaba Research, Inc. - Trussville Location, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Nagre-recruitPhase 3
- Birmingham Clinical Research, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Nagre-recruitPhase 3
- AURORA-2 Clinical Site, Birmingham
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Nagre-recruitPhase 2
- Central Research Associates - Flourish - PPDS, Birmingham
- AES - DRS - Synexus Clinical Research US, Inc. - Birmingham, Birmingham
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Nagre-recruitPhase 2
- Flourish Research, Birmingham
Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)
Nagre-recruit
- UAB Highlands Hospital/Department of Family and Community Medicine, Birmingham
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Nagre-recruitPhase 3
- Research Site, Birmingham
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Nagre-recruitPhase 3
- Univ of Alabama Birmingham, Birmingham
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Nagre-recruitPhase 3
- Research Site, Birmingham
CGM for Management of Type 2 Diabetes in Pregnancy
Nagre-recruit
- University of Alabama at Birmingham, Birmingham
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Nagre-recruitPhase 2
- Central Research Associates, LLC dba Flourish Research, Birmingham
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
Nagre-recruitObservasyonal na pag-aaral
- University of Alabama at Birmingham, Birmingham
FELLAShip to Better Health
Nagre-recruit
- The Worship Center Cristian Church, Birmingham
A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
Nagre-recruit
- University of Alabama at Birmingham/ Children's of Alabama, Birmingham
Pag-aaral para sa Type 2 Diabetes sa ibang lungsod
- San Antonio, TX37 pag-aaral
- Houston, TX31 pag-aaral
- Orlando, FL24 pag-aaral
- Boston, MA20 pag-aaral
- Miami, FL19 pag-aaral
- Chicago, IL19 pag-aaral
- Dallas, TX19 pag-aaral
- Columbus, OH18 pag-aaral
- Las Vegas, NV18 pag-aaral
- Atlanta, GA17 pag-aaral
- San Diego, CA17 pag-aaral
- Los Angeles, CA16 pag-aaral
Iba pang pag-aaral sa Birmingham
- Kanser (lahat ng uri)30 pag-aaral
- Kanser sa Suso24 pag-aaral
- Obesity23 pag-aaral
- Kanser sa Ovary23 pag-aaral
- Non-Small Cell Lung Cancer22 pag-aaral
- Acute Myeloid Leukemia21 pag-aaral
- Multiple Myeloma18 pag-aaral
- COPD17 pag-aaral
- Sakit sa Puso at Ugat ng Dugo17 pag-aaral
- Overweight16 pag-aaral
- Kanser ng Endometrium16 pag-aaral
- Cystic Fibrosis16 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.